Report

Medicines in Development: Heart Disease and Stroke Overview

Medicines in Development: Heart Disease and Stroke Overview

PhRMA June 18, 2013

Biopharmaceutical research companies are developing 215 medicines for two of the leading causes of death in Americans—heart disease and stroke. These therapies promise to build on the progress made by existing treatments, which have helped cut deaths from heart disease by a third between 2001 and 2011, according to the Centers for Disease Control and Prevention (CDC).

Download